Members Only The content below is member only

MGMA to CMS: Return to drawing board on Part B drugs payment model


On Monday, MGMA sent a comment letter to the Centers for Medicare & Medicaid Services (CMS), urging the agency not to move forward with its proposed Part B drug payment program.

To access the full content, select an option below.


Member Login Not a member? Start a free trial


Contact Information

Contact Congress Contact Congress


Not a Member?

Members have the opportunity to interact directly with the MGMA Government Affairs staff. 

Sign up for a 30-day MGMA trial!

Benefits of becoming an MGMA member:

  • Weekly Washington Connection e-newsletter
  • Access to expert Government Affairs staff
  • Timely resources and articles